– Company Receives Investigational Testing Authorization from Health Canada to Conduct Cervical Spinal Cord Injury Study – March 23, 2017 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Health Canada has approved the company’s Investigational Testing Authorization application to commence a clinical study of the Neuro-Spinal Scaffold™ in patients with acute, complete…
That All May Walk Again!